Charles Stacey, MD
President and CEO of Cerecin, USA
Dr. Charles Stacey is President and CEO of Cerecin, a clinical-stage biotechnology company developing innovative therapeutics for brain health and neurological diseases. Prior to joining Cerecin, Dr. Stacey was with Inventages, the Nestlé-backed healthcare venture capital group, with $1.5B under management. Prior to Inventages, Dr. Stacey ran an orthopedic medical device company and worked for a number of early-stage healthcare companies. He received his medical degree from King’s College London and practiced as a trauma and reconstructive surgeon. Dr. Stacey also completed an MBA at the London Business School and the Wharton School.